Lineage Cell Therapeutics Inc Sustainability Reports

Lineage Cell Therapeutics Inc. specializes in developing and commercializing cell-based therapies for degenerative eye diseases and spinal cord injuries.

Sector: Health Care

Country: United States

Exchange: NYSE American

ISIN: US53566P1093

3 reports from 2020 to 2023

Company Profile

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc. specializes in developing and commercializing cell-based therapies for degenerative eye diseases and spinal cord injuries.

MIC

 

Ticker

 

ISIN

 

Website

www.lineagecell.com

Country

United States

Exchange

NYSE American

Sector

Health Care

Industry

Health Care Equipment & Services

Reports

Available reports